3 days ago
Beyond Earth: How Space Is Transforming The Future Of Medicine
Shelli Brunswick is CEO & Founder of SB Global LLC and an international keynote speaker on tech used for the betterment of humanity.
2016 ESA/NASA
NASA's 2025 Spinoff report highlights a profound truth: Space exploration is no longer just about reaching distant worlds but improving life here on Earth. Technologies originally designed to protect astronauts now save lives, advance healthcare and reshape our future on Earth.
Among the many innovations featured, the Cardi/o Monitor is a noninvasive, wall-mounted system that continuously tracks vital signs like heart rate and respiration without touching the patient. Developed using NASA's expertise in remote sensing, this technology, once critical for monitoring astronaut health in space, is now revolutionizing home healthcare, offering patients greater freedom and clinicians earlier warnings of potential problems.
Space has always promised new frontiers. Yet some of the greatest discoveries are not on distant planets but within the laboratories orbiting above us, most notably, the International Space Station (ISS). As we venture farther from Earth, we uncover powerful tools to fight disease, extend life and enhance human well-being.
Central to these breakthroughs is the power of microgravity. Without Earth's pull, biological systems behave differently, unlocking unprecedented insights into disease progression, tissue regeneration and cardiovascular health. Microgravity is not just an environment—it is becoming medicine's next great frontier.
Blindness caused by degenerative retinal diseases like retinitis pigmentosa and age-related macular degeneration affects millions worldwide. Until recently, restoring meaningful vision for these patients was a distant dream. But that dream is moving closer to reality thanks to pioneering space-based research.
Under the leadership of Dr. Nicole Wagner, LambdaVision is revolutionizing vision restoration through protein-based retinal implants, and the unique environment of space is playing a critical role. On Earth, gravity interferes with the delicate layering of proteins necessary to build the implant, introducing imperfections that can compromise function. However, in the weightlessness of space, the layering process becomes dramatically more precise and stable, producing higher-quality implants with significantly improved potential for restoring sight.
Through partnerships with NASA and the ISS, LambdaVision has conducted nine spaceflight missions to refine its production techniques in microgravity. These experiments prove feasibility and accelerate the path toward clinical trials on Earth.
Beyond technical achievement, LambdaVision's work represents a larger shift: using space as a manufacturing platform for next-generation biomedical solutions. If successful, LambdaVision's implants could restore functional vision for millions, turning once-impossible hopes into transformative realities.
The future of sight may well be built among the stars—and thanks to innovations like these, the distance between space technology and everyday healing continues to shrink.
In the harsh environment of space, astronauts experience accelerated bone loss, losing bone mass up to 10 times faster than individuals with osteoporosis on Earth. What once posed a significant health risk for long-duration missions has transformed the ISS into an unprecedented laboratory for advancing bone health research. Scientists have uncovered critical pathways to combat osteoporosis and related conditions more effectively and efficiently by studying rapid skeletal degeneration in microgravity.
One groundbreaking result of this research is Bone Health Technologies' OsteoBoost, a device directly inspired by NASA's studies of microgravity's impact on skeletal strength. OsteoBoost uses precision-targeted vibration therapy to stimulate bone growth in the hips and spine—the areas most vulnerable to osteoporotic fractures. Unlike traditional pharmaceutical treatments, OsteoBoost offers a noninvasive, drug-free alternative to preserving bone density, minimizing side effects and empowering patients with greater control over their bone health.
Clinical trials demonstrated that regular use of OsteoBoost significantly slowed bone loss in postmenopausal women with osteopenia, ultimately leading to its FDA clearance through the De Novo pathway in 2024.
OsteoBoost exemplifies how solutions developed to protect astronaut health are now reshaping Earth-based medicine, offering new hope in fighting against one of our planet's most pervasive age-related health challenges.
Spaceflight presents extraordinary challenges to the human cardiovascular system. In microgravity, bodily fluids shift toward the head, blood vessels must adapt to new pressures and heart muscles undergo structural changes. While risky for astronauts, these adaptations have delivered profound insights into conditions like hypertension, clotting disorders and heart failure—insights that are now transforming cardiovascular care on Earth.
One of the most remarkable medical innovations born from this research is the MicroMed DeBakey Ventricular Assist Device (VAD). Developed through a groundbreaking collaboration between NASA, renowned heart surgeon Dr. Michael DeBakey, Dr. George Noon and MicroMed Technology, Inc., the VAD was engineered using NASA's expertise in fluid dynamics, originally designed for rocket engines. The result is a miniature heart pump weighing less than 4 ounces that can support patients with severe heart failure by maintaining blood circulation until a donor heart becomes available. Its compact, less-invasive design expanded treatment options for smaller adults and children, saving thousands of lives around the world.
Beyond the VAD, the ISS remains a vital research platform for understanding how extended periods in microgravity reshape the cardiovascular system. ISS-based studies are helping scientists better predict, prevent and treat cardiovascular deconditioning, leading to the development of countermeasures that protect astronaut health on long-duration missions and advance cardiovascular care for patients on Earth.
The journey from rocket engines to heart pumps illustrates vividly how space-based innovation improves, extends and saves human lives.
Space exploration has always promised to reveal distant worlds. Yet its greatest gift may be the transformation it brings to life on Earth. By removing the pull of gravity, space has accelerated breakthroughs once thought impossible, reshaping medicine, regenerating health and rewriting the future of care.
From restoring sight with space-grown implants to strengthening bones through microgravity insights and saving lives with heart pumps born from rocket science, the innovations forged above us are healing humanity below.
As new space stations rise and global public-private partnerships expand, the cosmos becomes a laboratory for hope, resilience and discovery. Space is no longer just our next frontier—it is the next horizon of healing.
Forbes Technology Council is an invitation-only community for world-class CIOs, CTOs and technology executives. Do I qualify?
